These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28413770)

  • 1. Biophysical regulation of cell reprogramming.
    Wong SY; Soto J; Li S
    Curr Opin Chem Eng; 2017 Feb; 15():95-101. PubMed ID: 28413770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering Biomaterials with Micro/Nanotechnologies for Cell Reprogramming.
    Fang J; Hsueh YY; Soto J; Sun W; Wang J; Gu Z; Khademhosseini A; Li S
    ACS Nano; 2020 Feb; 14(2):1296-1318. PubMed ID: 32011856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart regeneration for clinical application update 2016: from induced pluripotent stem cells to direct cardiac reprogramming.
    Yamakawa H
    Inflamm Regen; 2016; 36():23. PubMed ID: 29259696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct reprogramming of adult cells: avoiding the pluripotent state.
    Kelaini S; Cochrane A; Margariti A
    Stem Cells Cloning; 2014; 7():19-29. PubMed ID: 24627642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How induced pluripotent stem cells are redefining personalized medicine.
    Ferreira LM; Mostajo-Radji MA
    Gene; 2013 May; 520(1):1-6. PubMed ID: 23470844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential application of induced pluripotent stem cells in cell replacement therapy for Parkinson's disease.
    Chen LW; Kuang F; Wei LC; Ding YX; Yung KK; Chan YS
    CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):449-58. PubMed ID: 21495962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in cell lineage reprogramming.
    Zhou J; Yue W; Pei X
    Sci China Life Sci; 2013 Mar; 56(3):228-33. PubMed ID: 23526388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for heart regeneration: approaches ranging from induced pluripotent stem cells to direct cardiac reprogramming.
    Yamakawa H; Ieda M
    Int Heart J; 2015; 56(1):1-5. PubMed ID: 25742939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct Conversion of Somatic Cells into Induced Neurons.
    An N; Xu H; Gao WQ; Yang H
    Mol Neurobiol; 2018 Jan; 55(1):642-651. PubMed ID: 27981499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding Parkinson's Disease through the Use of Cell Reprogramming.
    Playne R; Connor B
    Stem Cell Rev Rep; 2017 Apr; 13(2):151-169. PubMed ID: 28083784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A potential role for insulin-like growth factor signaling in induction of pluripotent stem cell formation.
    Li Y; Geng YJ
    Growth Horm IGF Res; 2010 Dec; 20(6):391-8. PubMed ID: 20956084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct cardiac reprogramming: progress and challenges in basic biology and clinical applications.
    Sadahiro T; Yamanaka S; Ieda M
    Circ Res; 2015 Apr; 116(8):1378-91. PubMed ID: 25858064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical potential of human-induced pluripotent stem cells : Perspectives of induced pluripotent stem cells.
    Kumar D; Anand T; Kues WA
    Cell Biol Toxicol; 2017 Apr; 33(2):99-112. PubMed ID: 27900567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in cellular reprogramming: moving toward a reprieve from immunogenicity.
    Gallegos TF; Sancho-Martinez I; Izpisua Belmonte JC
    Immunol Lett; 2013; 155(1-2):14-7. PubMed ID: 24076314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical Integration-Free Episomal Methods for Generating Human Induced Pluripotent Stem Cells.
    Kime C; Rand TA; Ivey KN; Srivastava D; Yamanaka S; Tomoda K
    Curr Protoc Hum Genet; 2015 Oct; 87():21.2.1-21.2.21. PubMed ID: 26439714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Derivation of Transgene-Free Rat Induced Pluripotent Stem Cells Approximating the Quality of Embryonic Stem Cells.
    Li S; Lan H; Men H; Wu Y; Li N; Capecchi MR; Bryda EC; Wu S
    Stem Cells Transl Med; 2017 Feb; 6(2):340-351. PubMed ID: 28191784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reprogramming of somatic cells: iPS and iN cells.
    Broccoli V
    Prog Brain Res; 2017; 230():53-68. PubMed ID: 28552235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retroviral vector silencing during iPS cell induction: an epigenetic beacon that signals distinct pluripotent states.
    Hotta A; Ellis J
    J Cell Biochem; 2008 Nov; 105(4):940-8. PubMed ID: 18773452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficient generation of induced pluripotent stem (iPS) cells from adult mouse adipose tissue-derived and neural stem cells.
    Tat PA; Sumer H; Jones KL; Upton K; Verma PJ
    Cell Transplant; 2010; 19(5):525-36. PubMed ID: 20144262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct reprogramming and biomaterials for controlling cell fate.
    Kim E; Tae G
    Biomater Res; 2016; 20():39. PubMed ID: 27980804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.